Merck's hepatitis C drug granted priority review by FDA

January 6, 2011
The Food and Drug Administration granted priority review to an approval application for a hepatitis C drug made by Merck, the drug maker said Thursday.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Or, Create an Account >>

Comments

Post a Comment
May 27, 2011 - 19:54
cmichel says:

if and when approved what

if and when approved what strand is it for i have geno type 3a

© 2012 Drug Store News. All Rights Reserved.